Publication:
Effect of Hepatosteatosis on the Virological Response in Entecavir and Tenofovir Therapies

Placeholder

Organizational Units

Program

Authors

KORKMAZ, PINAR
Demirturk, Nese
Batirel, Ayse
Tulek, Necla
Ozguler, Muge
Harman, Rezan
Cinar, Gule
TOKA, ONUR
Yoruk, Gulsen
Ataman-Hatipoglu, Cigdem

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Objective: Both chronic hepatitis B (CHB) and hepatosteatosis may lead to necroinflammation in liver. Therefore, the presence of hepatosteatosis might negatively affect the efficacy of antiviral therapy. We aimed to determine the effect of hepatosteatosis on virological response in patients with CHB receiving entecavir (ETV) and tenofovir (TDF) treatment.

Description

Source:

Keywords:

Keywords

Citation

KORKMAZ P., Demirturk N., Batirel A., Tulek N., Ozguler M., Harman R., Cinar G., TOKA O., Yoruk G., Ataman-Hatipoglu C., et al., -Effect of Hepatosteatosis on the Virological Response in Entecavir and Tenofovir Therapies-, KLIMIK JOURNAL, cilt.32, ss.265-274, 2019

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads

View PlumX Details


Sustainable Development Goals

Thumbnail Image
Goal